Gonadal hormones in long-term survivors 10 years after treatment for unilateral testicular cancer.

@article{Nord2003GonadalHI,
  title={Gonadal hormones in long-term survivors 10 years after treatment for unilateral testicular cancer.},
  author={Carina Nord and Trine Bj\oro and Dag Gunnar Ellingsen and Arnstein Mykletun and Olav Dahl and Olbj\orn Harald Klepp and Roy Martin Bremnes and Erik Andreas Wist and Sophie D Fossa},
  journal={European urology},
  year={2003},
  volume={44 3},
  pages={322-8}
}
OBJECTIVE To investigate whether unilaterally orchiectomised testicular cancer survivors (TCSs) are more likely to display reduced Leydig cell function than healthy males. METHODS A national multi-centre survey of 1235 TCSs was performed in 1998-2000 (mean age: 44 years) treated between 1980 and 1994 (mean follow-up: 11 years). Serum hormone analyses were performed on 1183 TCSs, as 52 TCSs used androgen replacement (AR). TCSs were allocated to four treatment groups: Surgery only (251… CONTINUE READING